Detalles de la búsqueda
1.
Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
PLoS Pathog
; 20(4): e1012155, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593115
2.
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses.
J Infect Dis
; 227(7): 838-849, 2023 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35668700
3.
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults.
J Infect Dis
; 225(7): 1129-1140, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34888688
4.
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose.
J Infect Dis
; 226(6): 983-994, 2022 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35543278
5.
Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study.
J Antimicrob Chemother
; 77(4): 979-988, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35061879
6.
An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
PLoS Pathog
; 16(2): e1008307, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32069328
7.
Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication.
Nucleic Acids Res
; 45(7): 4051-4067, 2017 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27928057
8.
Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase Inhibitors.
J Infect Dis
; 218(11): 1773-1776, 2018 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010985
9.
The influence of culture on couples coping with breast cancer: a comparative analysis of couples from China, India, and the United States.
J Psychosoc Oncol
; 32(3): 264-88, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24611914
10.
T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy.
Viruses
; 16(5)2024 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38793543
11.
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
J Virol
; 86(12): 6913-23, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22496233
12.
SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy.
AIDS
; 37(5): F11-F18, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36789806
13.
Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine.
Open Forum Infect Dis
; 10(3): ofad073, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36910697
14.
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy.
AIDS
; 37(5): 709-721, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36545783
15.
Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third Dose.
medRxiv
; 2022 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35018381
16.
Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination.
Front Immunol
; 13: 947021, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36148225
17.
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.
NPJ Vaccines
; 7(1): 28, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35228535
18.
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.
medRxiv
; 2022 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35350205
19.
In vitro selection of clinically relevant bevirimat resistance mutations revealed by "deep" sequencing of serially passaged, quasispecies-containing recombinant HIV-1.
J Clin Microbiol
; 49(1): 201-8, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21084518
20.
2-Trifluoromethylthiazole-5-carboxamides: Analogues of a Stilbene-Based Anti-HIV Agent that Impact HIV mRNA Processing.
ACS Med Chem Lett
; 12(11): 1818-1823, 2021 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34795872